Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Chronic Heart Failure

Free Subscription 29.06.2026 5 Am J Cardiol 1 Cardiovasc Res 2 Circ Heart Fail 1 Circulation 1 Eur Heart J 5 Eur J Heart Fail 2 Heart 1 J Cardiovasc Pharmacol 1 J Mol Cell Cardiol 1 Lancet 3 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Cardiol

1. FERREIRA JP, Mascarenhas J, Marques P, Mendonca L, et al
   Cystatin-C versus creatinine and kidney function in heart failure with preserved ejection fraction: a SOGALDI-PEF analysis.
   Am J Cardiol. 2026 Jun 26:S0002-9149(26)00436.
   PubMed        
   
   
2. MEHTA A
   Acute Estimated Glomerular Filtration Rate Changes With Guideline Directed Medical Therapy Initiation In Heart Failure.
   Am J Cardiol. 2026 Jun 24:S0002-9149(26)00421.
   PubMed        
   
   
3. BELLICINI DMG
   Hypertensive Heart Disease: Risk Marker or Causal Substrate of Heart Failure?
   Am J Cardiol. 2026 Jun 22:S0002-9149(26)00430.
   PubMed         Abstract available
   
   
4. KAWATA T, Ikeda A
   Clinical factors associated with B-type natriuretic peptide reduction rate during hospitalization in patients with acute heart failure.
   Am J Cardiol. 2026 Jun 20:S0002-9149(26)00422.
   PubMed        
   
   
5. AHMED HM, Rehman UU, Owais M, Hamza M, et al
   Divergent Efficacy of GLP-1 Receptor Agonists in HFpEF Versus HFrEF: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
   Am J Cardiol. 2026;271:119-130.
   PubMed         Abstract available
   
   

   
   Cardiovasc Res

6. MAZZOLA M, Wang H, Lang D, Balycheva M, et al
   Loss of caveolar A1 adenosine receptor signalling blunts anti-adrenergic control in heart failure.
   Cardiovasc Res. 2026 Jun 24:cvag131. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Circ Heart Fail

7. BUTT JH, McMurray JJV
   Response by McMurray to Letter Regarding Article, "Finerenone, Liver Biomarkers, and Heart Failure With Mildly Reduced/Preserved Ejection Fraction: An Analysis of FINEARTS-HF".
   Circ Heart Fail. 2026 Jun 24:e014385. doi: 10.1161/CIRCHEARTFAILURE.126.014385.
   PubMed        
   
   
8. NIE Z, Xiong Q
   Letter by Nie and Xiong Regarding Article, "Finerenone, Liver Biomarkers, and Heart Failure With Mildly Reduced/Preserved Ejection Fraction: An Analysis of FINEARTS-HF".
   Circ Heart Fail. 2026 Jun 24:e014373. doi: 10.1161/CIRCHEARTFAILURE.126.014373.
   PubMed        
   
   

   
   Circulation

9. ADEDINSEWO DA, Brown HL, Hameed AB, McNamara D, et al
   Heart Failure Occurring in the Perinatal Period: A Scientific Statement From the American Heart Association.
   Circulation. 2026 Jun 24. doi: 10.1161/CIR.0000000000001450.
   PubMed         Abstract available
   
   

   
   Eur Heart J

10. CREA F
    Interaction of heart failure with chronic kidney disease, liver disease and cancer: the need for systems cardiology.
    Eur Heart J. 2026;47:3023-3029.
    PubMed        
    
    

    
    Eur J Heart Fail

11. ZONNEVELD LEEC, Ter Maaten JM, Voors AA, Schulze C, et al
    Early effects of SGLT2 inhibitors in acute heart failure: an individual patient-level meta-analysis.
    Eur J Heart Fail. 2026 Jun 23:xuag184. doi: 10.1093.
    PubMed         Abstract available
    
    
12. MARKWIRTH P, Hoevelmann J, Tokcan M, Haring B, et al
    What's new in heart failure? June 2026.
    Eur J Heart Fail. 2026 Jun 25:xuag204. doi: 10.1093.
    PubMed        
    
    
13. RUBIS P, Winiarczyk M, Dziewiecka E, Wisniowska-Smialek S, et al
    Circadian rhythms of core and skin temperature in heart failure.
    Eur J Heart Fail. 2026 Jun 25:xuag199. doi: 10.1093.
    PubMed        
    
    
14. TANG Y, Liu Y
    Letter regarding the article "Independent and Dose-Dependent Contributions of Clonal Hematopoiesis and Mosaic Loss of Y to Incident Heart Failure".
    Eur J Heart Fail. 2026 Jun 25:xuag212. doi: 10.1093.
    PubMed        
    
    
15. PACKER M
    Does Phenotypic Heterogeneity in Heart Failure With Preserved Ejection Fraction Imply Mechanistic Heterogeneity? The Myth of a Phenotype-Directed Therapeutic Framework and the Mandate for a Falsifiable Hypothesis.
    Eur J Heart Fail. 2026 Jun 26:xuag211. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Heart

16. NOMA H, Kurita N, Fukuma S, Fujisawa T, et al
    Heart failure and renal outcomes with angiotensin receptor blockers compared with calcium channel blockers in patients with chronic kidney disease: a target trial emulation.
    Heart. 2026 Jun 23:heartjnl-2026-328193. doi: 10.1136/heartjnl-2026-328193.
    PubMed         Abstract available
    
    
17. PNG ME, Tahsina T, Jones NR, Taylor CJ, et al
    Cost-effectiveness of N-terminal pro-B-type natriuretic peptide thresholds for echocardiography referral in primary care heart failure management.
    Heart. 2026 Jun 26:heartjnl-2026-328059. doi: 10.1136/heartjnl-2026-328059.
    PubMed         Abstract available
    
    

    
    J Cardiovasc Pharmacol

18. LOEB SA, Tharp DL, Zawieja SD, Pal S, et al
    Pitfalls of therapies targeting the nitric oxide signaling pathway in heart failure with preserved ejection fraction.
    J Cardiovasc Pharmacol. 2026 Jun 22. doi: 10.1097/FJC.0000000000001844.
    PubMed         Abstract available
    
    

    
    J Mol Cell Cardiol

19. TADOKORO T, Liu N, Olson EN
    Precision modification of heart failure signaling by CRISPR-Cas9 base editing.
    J Mol Cell Cardiol. 2026 Jun 19:S0022-2828(26)00092.
    PubMed         Abstract available
    
    

    
    Lancet

20. LUND LH, Barandiaran Aizpurua A, Bollano E, Braun O, et al
    Safety, pharmacokinetics, and exploratory efficacy of the oral ghrelin receptor agonist AC01 in heart failure with reduced ejection fraction (GOAL-HF1): a randomised, double-blind, placebo-controlled, phase 1b/2a study.
    Lancet. 2026 Jun 24:S0140-6736(26)00904-9. doi: 10.1016/S0140-6736(26)00904.
    PubMed         Abstract available
    
    

    
    PLoS One

21. WU Z, Zheng Z, Li Y, Li B, et al
    Integrated NEK7-inflammasome and platelet transcriptomic signature generates mechanistic hypotheses in heart failure.
    PLoS One. 2026;21:e0352124.
    PubMed         Abstract available
    
    
22. KOKORELIAS KM, Huang YQ, Harris MT, Hoang PM, et al
    Prevalence of heart failure and coronary artery disease in older adults experiencing homelessness: A systematic review and meta-analysis protocol with a consultative exercise.
    PLoS One. 2026;21:e0345868.
    PubMed         Abstract available
    
    
23. SHEARER JJ, Joo J, Downie CG, Kuku KO, et al
    Proteomics risk scores and mortality in heart failure: Generalizability across populations.
    PLoS One. 2026;21:e0350697.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum